Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans

Millions of individuals are diagnosed with type 2 diabetes mellitus (T2D), which increases the risk for a plethora of adverse outcomes including cardiovascular events and kidney disease. Metformin is the most widely prescribed medication for the treatment of T2D; however, its mechanism is not fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotroff, Daniel M., Oki, Noffisat O., Liang, Xiaomin, Yee, Sook Wah, Stocker, Sophie L., Corum, Daniel G., Meisner, Michele, Fiehn, Oliver, Motsinger-Reif, Alison A., Giacomini, Kathleen M., Kaddurah-Daouk, Rima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906013/
https://www.ncbi.nlm.nih.gov/pubmed/27378919
http://dx.doi.org/10.3389/fphar.2016.00135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906013/
https://www.ncbi.nlm.nih.gov/pubmed/27378919
http://dx.doi.org/10.3389/fphar.2016.00135

Ejemplares similares